Cosmo Rossi
Impact in
- Biochemistry top 2%
- Phytochemicals and Antioxidant Activities
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
Papers in
-
- Cancer therapeutics and mechanisms 8
- Glycosylation and Glycoproteins Research 4
- Retinoids in leukemia and cellular processes 3
- Oncology 18
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 4
- Co-authors
- Mauro Piantelli (15 shared papers)Maurizio Ricci (1 shared paper)Stefano Giovagnoli (1 shared paper)Paolo Blasi (1 shared paper)Aurélie Schoubben (1 shared paper)Andreina Poggi (4 shared papers)Pier Giorgio Natali (6 shared papers)Stefano Iacobelli (16 shared papers)
- Journals
- Cancer Research (4 papers)PLoS ONE (3 papers)International Journal of Cancer (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Annals of Oncology (2 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Cosmo Rossi
69 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 136
- Biochemistry 199
- Pharmaceutical Science 193
- Oncology 660
- Cancer Research 286
- Molecular Biology 1.4k
Countries citing papers authored by Cosmo Rossi
This map shows the geographic impact of Cosmo Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cosmo Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cosmo Rossi more than expected).
Fields of papers citing papers by Cosmo Rossi
This network shows the impact of papers produced by Cosmo Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cosmo Rossi. The network helps show where Cosmo Rossi may publish in the future.
Co-authors
The 25 scholars most cited alongside Cosmo Rossi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 388 | |
| 2 | 2000 | 380 | |
| 3 | 2005 | 138 | |
| 4 | 2011 | 130 | |
| 5 | 2008 | 128 | |
| 6 | 2008 | 113 | |
| 7 | 2005 | 103 | |
| 8 | 1999 | 99 | |
| 9 | Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function. | 1986 | 86 |
| 10 | 2010 | 78 | |
| 11 | 1984 | 75 | |
| 12 | 2005 | 75 | |
| 13 | 2008 | 74 | |
| 14 | 2001 | 67 | |
| 15 | IDN5109, a taxane with oral bioavailability and potent antitumor activity. | 2000 | 63 |
| 16 | 2006 | 58 | |
| 17 | 2009 | 57 | |
| 18 | 2014 | 57 | |
| 19 | 2017 | 52 | |
| 20 | 2010 | 50 |
About Cosmo Rossi
Cosmo Rossi is a scholar working on Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 70 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (4 papers), Neuroblastoma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (4 papers), Retinoids in leukemia and cellular processes (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Biochemistry (199 citations), Pharmaceutical Science (193 citations), Oncology (660 citations), Cancer Research (286 citations) and Molecular Biology (1.4k citations). Cosmo Rossi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Mauro Piantelli, Maurizio Ricci, Stefano Giovagnoli, Paolo Blasi, Aurélie Schoubben, Andreina Poggi, Pier Giorgio Natali, Stefano Iacobelli, Maurizio D’Incalci and Franco O. Ranelletti. Their work appears in journals such as Cancer Research, PLoS ONE, International Journal of Cancer, Cancer Chemotherapy and Pharmacology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.